Core Viewpoint - Lepu Medical's stock closed at 11.27 yuan, down 1.23%, with a rolling PE ratio of 147.59 times, indicating a high valuation compared to the industry average [1] Group 1: Company Overview - Lepu Medical's main business includes medical devices, pharmaceuticals, medical services, and health management [1] - The latest quarterly report for Q1 2025 shows revenue of 1.736 billion yuan, a year-on-year decrease of 9.67%, and a net profit of 379 million yuan, down 21.44%, with a gross margin of 64.03% [1] Group 2: Shareholder Information - As of March 31, 2025, Lepu Medical had 94,228 shareholders, an increase of 583 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 3: Industry Comparison - The average PE ratio for the medical device industry is 49.46 times, with a median of 36.16 times, positioning Lepu Medical at the 110th rank within the industry [2]
乐普医疗收盘下跌1.23%,滚动市盈率147.59倍,总市值211.94亿元